We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK’s Development of Avandia Under Federal Investigation
GSK’s Development of Avandia Under Federal Investigation
October 27, 2010
GlaxoSmithKline (GSK) is under investigation for actions related to the development and marketing of its diabetes drug Avandia.